IOVANCE BIOTHERAPEUTICS, INC. Material Contracts
Every material contract the company filed as Exhibit 10 (executive pay plans, credit agreements, supplier and indemnity agreements), newest first, with the filing's own description.
- 2026-08-06: Form 10-Q; Exhibit 10.2; Description Consulting Agreement, effective as of June 9, 2026, by and between Friedrich-Reinhard Graf Finck von Finckensten, M.D., and the Registrant..
- 2026-08-06: Form 10-Q; Exhibit 10.1; Description Separation Agreement and General Release, dated June 8, 2026, by and between Friedrich-Reinhard Graf Finck von Finckensten, M.D., and the Registrant..
- 2026-02-24: Form 10-K; Exhibit 10.32; Description First Amendment to Executive Employment Agreement, effective as of December 3, 2025, by and between Daniel Gordon Kirby and Iovance Biotherapeutics, Inc.**#+.
- 2025-11-06: Form 10-Q; Exhibit 10.1; Description Executive Employment Agreement, effective as of August 6, 2025, by and between Corleen Roche and Iovance Biotherapeutics, Inc..
| Filed | Form | Exhibit | Description |
|---|
| 2026-08-06 | 10-Q | 10.2 | Consulting Agreement, effective as of June 9, 2026, by and between Friedrich-Reinhard Graf Finck von Finckensten, M.D., and the Registrant. |
|---|
| 2026-08-06 | 10-Q | 10.1 | Separation Agreement and General Release, dated June 8, 2026, by and between Friedrich-Reinhard Graf Finck von Finckensten, M.D., and the Registrant. |
|---|
| 2026-02-24 | 10-K | 10.32 | First Amendment to Executive Employment Agreement, effective as of December 3, 2025, by and between Daniel Gordon Kirby and Iovance Biotherapeutics, Inc.**#+ |
|---|